Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03606434 · ClinicalTrials.gov registry record · NA

Sex Differences in Reflex Responses to Intermittent Hypoxia

A NA study, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT03606434 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03606434, a NA study, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The purpose of the present study is to determine whether there are sex differences in the reflex responses to hypoxia in humans.

Interventions

  • OTHER Hypoxic exposure

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-09-13
Est. Completion 2021-07-15
Phase NA

Sponsor

University of Missouri-Columbia

291 total trials

What the Registry Record Tells You About NCT03606434

The ClinicalTrials.gov registry entry for NCT03606434 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Hypoxic exposure is the first listed.

NCT03606434 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03606434 about?

NCT03606434 is a clinical study titled "Sex Differences in Reflex Responses to Intermittent Hypoxia". The purpose of the present study is to determine whether there are sex differences in the reflex responses to hypoxia in humans.

What is the current status of trial NCT03606434?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-09-13. Estimated completion is 2021-07-15.

What interventions are being tested in trial NCT03606434?

The interventions under investigation include: Hypoxic exposure (OTHER).

Who is sponsoring clinical trial NCT03606434?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.